<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1444">
  <stage>Registered</stage>
  <submitdate>4/07/2006</submitdate>
  <approvaldate>3/08/2006</approvaldate>
  <actrnumber>ACTRN12606000329561</actrnumber>
  <trial_identification>
    <studytitle>Sertraline Heart Study</studytitle>
    <scientifictitle>Efficacy of low dose Sertraline v's placebo in the amelioration of anxiety in heart disease.</scientifictitle>
    <utrn />
    <trialacronym>Nil</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Heart disease</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Anxiety</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention 5mg Sertraline in a lactose base in an identical capsule. 1 d for 12/52 via oral route. The complete period of the trial is ~3 months.</interventions>
    <comparator>Control: Lactose in an opaque capsule.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Reduction in anxiety</outcome>
      <timepoint>Measured at 6 weeks and again at 12 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Reduction in depression, reduction in fatigue, increase in effort tolerance and increase in quality of life.</outcome>
      <timepoint>All will be measured at 6 and 12 weeks.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Abnormal echocardiogram with history of any cardiac symptoms.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>85</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Malignancy &amp; Psychotrophics.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation involved contacting the holder of the allocation schedule who was off-site</concealment>
    <sequence>Simple randomisation by using a randomisation table created by a computer based statistical program</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/01/2006</anticipatedstartdate>
    <actualstartdate>1/01/2006</actualstartdate>
    <anticipatedenddate />
    <actualenddate>1/07/2007</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize>1</actualsamplesize>
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
    <hospital>St John of God Hospital, Subiaco - Subiaco</hospital>
    <postcode>6008 - Subiaco</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>Mood Research Foundation (WA) Inc</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Mood Research Foundation (WA) Inc.</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The low dose Sertraline Heart Study is a 3 month study evaluating improvements in energy, stress and well-being with very low dose Sertraline in patients with stable heart disease. Associated benefits may include improved sleep, weight and blood pressure. Being a serotonin reuptake inhibitor, we are also interested to monitor improvements in anxiety and mood, which have never been evaluated at this very low dose before. Half of the participants will receive 'blank' or placebo capsules. There are 4 visits to the study centre over the 3 months, at which symptoms will be monitored. Blood tests are undertaken initially and at 6 weeks. Subjects, Research Assistant and Medical Director are all blinded.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St John of God Hospital Subiaco Campus</ethicname>
      <ethicaddress />
      <ethicapprovaldate>7/10/2004</ethicapprovaldate>
      <hrec>132</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Dr Simon Dimmitt</name>
      <address>Suite 304/25
McCourt St
Subiaco WA 6008</address>
      <phone>+61 8 93829580</phone>
      <fax>+61 8 93829586</fax>
      <email>sdimmitt@bigpond.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Dr Simon Dimmitt</name>
      <address>Suite 304/25
McCourt St
Subiaco WA 6008</address>
      <phone>+61 8 93829580</phone>
      <fax>+61 8 93829586</fax>
      <email>sdimmitt@bigpond.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Simon Dimmitt </name>
      <address>c/o 3/10 McCourt St
WEST LEEDERVILLE  WA  6007</address>
      <phone>08 63809585</phone>
      <fax />
      <email>alicia@achf.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>